Shenzhen Bioeasy Biotechnology Co., Ltd. (300942.SZ)
- Previous Close
6.80 - Open
6.57 - Bid 6.97 x --
- Ask 6.99 x --
- Day's Range
6.72 - 7.11 - 52 Week Range
5.25 - 16.88 - Volume
4,318,400 - Avg. Volume
6,665,468 - Market Cap (intraday)
2.798B - Beta (5Y Monthly) 0.62
- PE Ratio (TTM)
-- - EPS (TTM)
-0.41 - Earnings Date --
- Forward Dividend & Yield 0.02 (0.30%)
- Ex-Dividend Date May 31, 2023
- 1y Target Est
--
Shenzhen Bioeasy Biotechnology Co., Ltd. develops and sells rapid testing instruments and reagents in China. The company offers cereals and feed, milk antibiotic, meat and seafood, honey antibiotic, and pesticides rapid test kits. It also offers veterinary, coronavirus, and DNA / RNA extraction kits, as well as provides drug of abuse screening tests. In addition, the company offers medical rapid test for tropical infectious and gastrointestinai disease; and purification related rapid test kits. Shenzhen Bioeasy Biotechnology Co., Ltd. was founded in 2007 and is based in Shenzhen, China.
www.bioeasy.comRelated News
Performance Overview: 300942.SZ
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300942.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300942.SZ
Valuation Measures
Market Cap
2.80B
Enterprise Value
2.54B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.85
Price/Book (mrq)
2.95
Enterprise Value/Revenue
9.08
Enterprise Value/EBITDA
-14.90
Financial Highlights
Profitability and Income Statement
Profit Margin
-58.79%
Return on Assets (ttm)
-7.87%
Return on Equity (ttm)
-16.63%
Revenue (ttm)
279.9M
Net Income Avi to Common (ttm)
-164.56M
Diluted EPS (ttm)
-0.41
Balance Sheet and Cash Flow
Total Cash (mrq)
648.55M
Total Debt/Equity (mrq)
41.19%
Levered Free Cash Flow (ttm)
3.27M
Company Insights: 300942.SZ
300942.SZ does not have Company Insights